| Terrence H Liu, MD | |
|
1411 E 31st St, Oakland, CA 94602-1018 | |
| (510) 437-4965 | |
| Not Available |
| Full Name | Terrence H Liu |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 1411 E 31st St, Oakland, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205977345 | NPI | - | NPPES |
| 00C509120 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | C50912 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alta Bates Summit Medical Center | Oakland, CA | Hospital |
| Alta Bates Summit Medical Center - Alta Bates Camp | Berkeley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
A new study has investigated how exposure to certain triggers can increase the risk of type 1 diabetes.
CIGNA HealthCare announced today that it is one of four companies to have been awarded a contract to provide medical benefits to Arizona's state employees, university employees and retirees. The contract becomes effective October 1, 2009.
A research team of scientists from EMBL Grenoble and the IGBMC in Strasbourg, France, have, for the first time, described in molecular detail the architecture of the central scaffold of TFIID: the human protein complex essential for transcription from DNA to mRNA. The study, published today in Nature, opens new perspectives in the study of transcription and of the structure and mechanism of other large multi-protein assemblies involved in gene regulation.
With the heroin epidemic in the United States reaching deadlier heights, Jacksonville-based Lakeview Health drug and alcohol treatment center's Dr. Philip Hemphill is helping to explain why fentanyl is causing a new wave of overdoses. Because Fentanyl is approximately 40 to 50 times more potent than pharmaceutical grade heroin and often illegally purchased unknowingly by recreational users as heroin, the risk of death skyrockets.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 6 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
A new study has investigated how exposure to certain triggers can increase the risk of type 1 diabetes.
CIGNA HealthCare announced today that it is one of four companies to have been awarded a contract to provide medical benefits to Arizona's state employees, university employees and retirees. The contract becomes effective October 1, 2009.
A research team of scientists from EMBL Grenoble and the IGBMC in Strasbourg, France, have, for the first time, described in molecular detail the architecture of the central scaffold of TFIID: the human protein complex essential for transcription from DNA to mRNA. The study, published today in Nature, opens new perspectives in the study of transcription and of the structure and mechanism of other large multi-protein assemblies involved in gene regulation.
With the heroin epidemic in the United States reaching deadlier heights, Jacksonville-based Lakeview Health drug and alcohol treatment center's Dr. Philip Hemphill is helping to explain why fentanyl is causing a new wave of overdoses. Because Fentanyl is approximately 40 to 50 times more potent than pharmaceutical grade heroin and often illegally purchased unknowingly by recreational users as heroin, the risk of death skyrockets.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Terrence H Liu, MD 5528 Pacheco Blvd, Ste A, Pacheco, CA 94553-5126 Ph: (925) 363-8170 | Terrence H Liu, MD 1411 E 31st St, Oakland, CA 94602-1018 Ph: (510) 437-4965 |
News Archive
A new study has investigated how exposure to certain triggers can increase the risk of type 1 diabetes.
CIGNA HealthCare announced today that it is one of four companies to have been awarded a contract to provide medical benefits to Arizona's state employees, university employees and retirees. The contract becomes effective October 1, 2009.
A research team of scientists from EMBL Grenoble and the IGBMC in Strasbourg, France, have, for the first time, described in molecular detail the architecture of the central scaffold of TFIID: the human protein complex essential for transcription from DNA to mRNA. The study, published today in Nature, opens new perspectives in the study of transcription and of the structure and mechanism of other large multi-protein assemblies involved in gene regulation.
With the heroin epidemic in the United States reaching deadlier heights, Jacksonville-based Lakeview Health drug and alcohol treatment center's Dr. Philip Hemphill is helping to explain why fentanyl is causing a new wave of overdoses. Because Fentanyl is approximately 40 to 50 times more potent than pharmaceutical grade heroin and often illegally purchased unknowingly by recreational users as heroin, the risk of death skyrockets.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 6 days ago
Dr. Cheryl Lin Park, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4743 | |
Dr. Rachel Gomez, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Department Of Surgery, Oakland, CA 94602 Phone: 510-437-4965 Fax: 510-437-5127 | |
Veronica C. Shim, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Beverly L. Bolinger, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Dr. Elizabeth L. Cureton, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 Fax: 510-437-5127 | |
Steven T Yedlin, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3100 Telegraph Ave, 2nd Floor Bayside Medical Group, Oakland, CA 94609 Phone: 510-452-5231 Fax: 510-889-8392 | |
Collin A Mbanugo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Webster St, Suite 900, Oakland, CA 94609 Phone: 510-272-9610 Fax: 510-272-9612 |